In T cells, TGF-β transcriptionally represses genes encoding several key proteins, such as perforin, granzyme, and IFN-γ, thereby negatively regulating the activity of cytotoxic T lymphocytes (CTLs), which destroy tumor cells. The gene discussed is TGFB1; the disease is neoplasm.